- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x K: POTASSIUM ION(Non-covalent)
K.2: 6 residues within 4Å:- Chain A: N.69, S.71, D.102, T.103, S.228, K.255
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:S.71, A:D.102, A:T.103
K.19: 6 residues within 4Å:- Chain B: N.69, S.71, D.102, T.103, S.228, K.255
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:S.71, B:D.102, B:T.103
K.36: 6 residues within 4Å:- Chain C: N.69, S.71, D.102, T.103, S.228, K.255
3 PLIP interactions:3 interactions with chain C- Metal complexes: C:S.71, C:D.102, C:T.103
K.53: 6 residues within 4Å:- Chain D: N.69, S.71, D.102, T.103, S.228, K.255
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:S.71, D:D.102, D:T.103
- 4 x PYR: PYRUVIC ACID(Non-covalent)
PYR.3: 11 residues within 4Å:- Chain A: R.67, K.255, E.257, A.278, R.279, G.280, D.281, T.313, M.345
- Ligands: MG.1, PEG.7
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:K.255, A:G.280, A:D.281, A:T.313, A:T.313
- Water bridges: A:R.67
PYR.20: 11 residues within 4Å:- Chain B: R.67, K.255, E.257, A.278, R.279, G.280, D.281, T.313, M.345
- Ligands: MG.18, PEG.24
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:K.255, B:G.280, B:D.281, B:T.313, B:T.313
- Water bridges: B:R.67
PYR.37: 11 residues within 4Å:- Chain C: R.67, K.255, E.257, A.278, R.279, G.280, D.281, T.313, M.345
- Ligands: MG.35, PEG.41
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:K.255, C:G.280, C:D.281, C:T.313
- Water bridges: C:R.67
PYR.54: 11 residues within 4Å:- Chain D: R.67, K.255, E.257, A.278, R.279, G.280, D.281, T.313, M.345
- Ligands: MG.52, PEG.58
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:K.255, D:G.280, D:D.281, D:T.313
- Water bridges: D:R.67
- 28 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.4: 5 residues within 4Å:- Chain A: G.221, N.223, S.443, K.446
- Ligands: PEG.5
Ligand excluded by PLIPPEG.5: 8 residues within 4Å:- Chain A: F.82, L.86, Q.89, L.97, M.99, M.220, K.446
- Ligands: PEG.4
Ligand excluded by PLIPPEG.7: 7 residues within 4Å:- Chain A: D.162, N.192, G.280, D.281, T.313
- Ligands: PYR.3, GOL.15
Ligand excluded by PLIPPEG.8: 7 residues within 4Å:- Chain A: Q.25, E.28, N.30, L.368, E.369, A.372
- Chain B: K.290
Ligand excluded by PLIPPEG.9: 5 residues within 4Å:- Chain A: D.234, R.237, L.238, N.241
- Ligands: GOL.13
Ligand excluded by PLIPPEG.10: 4 residues within 4Å:- Chain A: A.233, D.234, R.237, K.267
Ligand excluded by PLIPPEG.11: 11 residues within 4Å:- Chain A: M.15, S.17, N.303, V.337, L.338, D.339, G.340, I.374, L.379, K.430, R.452
Ligand excluded by PLIPPEG.21: 5 residues within 4Å:- Chain B: G.221, N.223, S.443, K.446
- Ligands: PEG.22
Ligand excluded by PLIPPEG.22: 8 residues within 4Å:- Chain B: F.82, L.86, Q.89, L.97, M.99, M.220, K.446
- Ligands: PEG.21
Ligand excluded by PLIPPEG.24: 7 residues within 4Å:- Chain B: D.162, N.192, G.280, D.281, T.313
- Ligands: PYR.20, GOL.32
Ligand excluded by PLIPPEG.25: 7 residues within 4Å:- Chain A: K.290
- Chain B: Q.25, E.28, N.30, L.368, E.369, A.372
Ligand excluded by PLIPPEG.26: 5 residues within 4Å:- Chain B: D.234, R.237, L.238, N.241
- Ligands: GOL.30
Ligand excluded by PLIPPEG.27: 4 residues within 4Å:- Chain B: A.233, D.234, R.237, K.267
Ligand excluded by PLIPPEG.28: 11 residues within 4Å:- Chain B: M.15, S.17, N.303, V.337, L.338, D.339, G.340, I.374, L.379, K.430, R.452
Ligand excluded by PLIPPEG.38: 5 residues within 4Å:- Chain C: G.221, N.223, S.443, K.446
- Ligands: PEG.39
Ligand excluded by PLIPPEG.39: 8 residues within 4Å:- Chain C: F.82, L.86, Q.89, L.97, M.99, M.220, K.446
- Ligands: PEG.38
Ligand excluded by PLIPPEG.41: 7 residues within 4Å:- Chain C: D.162, N.192, G.280, D.281, T.313
- Ligands: PYR.37, GOL.49
Ligand excluded by PLIPPEG.42: 7 residues within 4Å:- Chain C: Q.25, E.28, N.30, L.368, E.369, A.372
- Chain D: K.290
Ligand excluded by PLIPPEG.43: 5 residues within 4Å:- Chain C: D.234, R.237, L.238, N.241
- Ligands: GOL.47
Ligand excluded by PLIPPEG.44: 4 residues within 4Å:- Chain C: A.233, D.234, R.237, K.267
Ligand excluded by PLIPPEG.45: 11 residues within 4Å:- Chain C: M.15, S.17, N.303, V.337, L.338, D.339, G.340, I.374, L.379, K.430, R.452
Ligand excluded by PLIPPEG.55: 5 residues within 4Å:- Chain D: G.221, N.223, S.443, K.446
- Ligands: PEG.56
Ligand excluded by PLIPPEG.56: 8 residues within 4Å:- Chain D: F.82, L.86, Q.89, L.97, M.99, M.220, K.446
- Ligands: PEG.55
Ligand excluded by PLIPPEG.58: 7 residues within 4Å:- Chain D: D.162, N.192, G.280, D.281, T.313
- Ligands: PYR.54, GOL.66
Ligand excluded by PLIPPEG.59: 7 residues within 4Å:- Chain C: K.290
- Chain D: Q.25, E.28, N.30, L.368, E.369, A.372
Ligand excluded by PLIPPEG.60: 5 residues within 4Å:- Chain D: D.234, R.237, L.238, N.241
- Ligands: GOL.64
Ligand excluded by PLIPPEG.61: 4 residues within 4Å:- Chain D: A.233, D.234, R.237, K.267
Ligand excluded by PLIPPEG.62: 11 residues within 4Å:- Chain D: M.15, S.17, N.303, V.337, L.338, D.339, G.340, I.374, L.379, K.430, R.452
Ligand excluded by PLIP- 24 x GOL: GLYCEROL(Non-functional Binders)
GOL.6: 7 residues within 4Å:- Chain A: P.106, M.193, N.194, L.195, V.200, F.229, E.285
Ligand excluded by PLIPGOL.12: 7 residues within 4Å:- Chain A: R.240, R.248, H.249, I.250, K.251, D.273
- Ligands: GOL.16
Ligand excluded by PLIPGOL.13: 5 residues within 4Å:- Chain A: I.205, D.234, D.235, L.238
- Ligands: PEG.9
Ligand excluded by PLIPGOL.14: 6 residues within 4Å:- Chain A: R.35, K.37, H.40, G.62, D.64, T.455
Ligand excluded by PLIPGOL.15: 7 residues within 4Å:- Chain A: H.72, R.109, A.161, D.162, K.191, N.192
- Ligands: PEG.7
Ligand excluded by PLIPGOL.16: 6 residues within 4Å:- Chain A: V.236, R.240, I.252, E.271, D.273
- Ligands: GOL.12
Ligand excluded by PLIPGOL.23: 7 residues within 4Å:- Chain B: P.106, M.193, N.194, L.195, V.200, F.229, E.285
Ligand excluded by PLIPGOL.29: 7 residues within 4Å:- Chain B: R.240, R.248, H.249, I.250, K.251, D.273
- Ligands: GOL.33
Ligand excluded by PLIPGOL.30: 5 residues within 4Å:- Chain B: I.205, D.234, D.235, L.238
- Ligands: PEG.26
Ligand excluded by PLIPGOL.31: 6 residues within 4Å:- Chain B: R.35, K.37, H.40, G.62, D.64, T.455
Ligand excluded by PLIPGOL.32: 7 residues within 4Å:- Chain B: H.72, R.109, A.161, D.162, K.191, N.192
- Ligands: PEG.24
Ligand excluded by PLIPGOL.33: 6 residues within 4Å:- Chain B: V.236, R.240, I.252, E.271, D.273
- Ligands: GOL.29
Ligand excluded by PLIPGOL.40: 7 residues within 4Å:- Chain C: P.106, M.193, N.194, L.195, V.200, F.229, E.285
Ligand excluded by PLIPGOL.46: 7 residues within 4Å:- Chain C: R.240, R.248, H.249, I.250, K.251, D.273
- Ligands: GOL.50
Ligand excluded by PLIPGOL.47: 5 residues within 4Å:- Chain C: I.205, D.234, D.235, L.238
- Ligands: PEG.43
Ligand excluded by PLIPGOL.48: 6 residues within 4Å:- Chain C: R.35, K.37, H.40, G.62, D.64, T.455
Ligand excluded by PLIPGOL.49: 7 residues within 4Å:- Chain C: H.72, R.109, A.161, D.162, K.191, N.192
- Ligands: PEG.41
Ligand excluded by PLIPGOL.50: 6 residues within 4Å:- Chain C: V.236, R.240, I.252, E.271, D.273
- Ligands: GOL.46
Ligand excluded by PLIPGOL.57: 7 residues within 4Å:- Chain D: P.106, M.193, N.194, L.195, V.200, F.229, E.285
Ligand excluded by PLIPGOL.63: 7 residues within 4Å:- Chain D: R.240, R.248, H.249, I.250, K.251, D.273
- Ligands: GOL.67
Ligand excluded by PLIPGOL.64: 5 residues within 4Å:- Chain D: I.205, D.234, D.235, L.238
- Ligands: PEG.60
Ligand excluded by PLIPGOL.65: 6 residues within 4Å:- Chain D: R.35, K.37, H.40, G.62, D.64, T.455
Ligand excluded by PLIPGOL.66: 7 residues within 4Å:- Chain D: H.72, R.109, A.161, D.162, K.191, N.192
- Ligands: PEG.58
Ligand excluded by PLIPGOL.67: 6 residues within 4Å:- Chain D: V.236, R.240, I.252, E.271, D.273
- Ligands: GOL.63
Ligand excluded by PLIP- 4 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
MES.17: 8 residues within 4Å:- Chain A: N.33, R.35, D.60, L.91, R.92, P.93, N.94, C.95
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.33, A:N.94, A:N.94, A:C.95
MES.34: 8 residues within 4Å:- Chain B: N.33, R.35, D.60, L.91, R.92, P.93, N.94, C.95
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:N.33, B:N.94, B:N.94, B:C.95
MES.51: 8 residues within 4Å:- Chain C: N.33, R.35, D.60, L.91, R.92, P.93, N.94, C.95
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:N.33, C:N.94, C:N.94, C:C.95
MES.68: 8 residues within 4Å:- Chain D: N.33, R.35, D.60, L.91, R.92, P.93, N.94, C.95
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:N.33, D:N.94, D:N.94, D:C.95
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dillenberger, M. et al., Prominent role of cysteine residues C49 and C343 in regulating Plasmodium falciparum pyruvate kinase activity. Structure (2022)
- Release Date
- 2022-08-24
- Peptides
- Pyruvate kinase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x K: POTASSIUM ION(Non-covalent)
- 4 x PYR: PYRUVIC ACID(Non-covalent)
- 28 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 24 x GOL: GLYCEROL(Non-functional Binders)
- 4 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dillenberger, M. et al., Prominent role of cysteine residues C49 and C343 in regulating Plasmodium falciparum pyruvate kinase activity. Structure (2022)
- Release Date
- 2022-08-24
- Peptides
- Pyruvate kinase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A